Strategies to overcome the hurdles to treat fibrosis, a major unmet clinical need
Fibroproliferative disorders are estimated to contribute to 45% of deaths in the United States (1). Although this huge number includes atherosclerosis, the biggest killer in the developed world, less common conditions, such as idiopathic pulmonary fibrosis, fibrosis of the liver and kidney, and syst...
| Κύριοι συγγραφείς: | , |
|---|---|
| Μορφή: | Journal article |
| Έκδοση: |
National Academy of Sciences
2016
|